Meropenem 125mg Injection PCD Company in Maharashtra

Meropenem Injection 125mg Franchise Supplier in Karnataka

Meropenem 125mg Injection Manufacturer in Himachal Pradesh

Best PCD Pharma for Meropenem 125mg Injection in Gujarat

Meropenem 125mg Injection Third Party Manufacturer in Punjab
Meropenem 125mg Injection Exporter from India

Home/Products /meropenem-125mg-10-10

About the Product

Description


Merotyle 125 Injection contains Meropenem (125mg), a broad-spectrum carbapenem antibiotic used to treat a wide range of serious bacterial infections, including those caused by multidrug-resistant organisms. Meropenem works by inhibiting bacterial cell wall synthesis, making it highly effective against both Gram-positive and Gram-negative bacteria, including anaerobes. It is often used in hospitals for life-threatening or complicated infections.

It helps in the treatment of serious infections such as lower respiratory tract infections, intra-abdominal infections, skin and soft tissue infections, urinary tract infections, bacterial meningitis, and septicemia, particularly in critically ill or hospitalized patients.

Common side effects may include nausea, vomiting, diarrhea, headache, rash, or pain at the injection site. Rare but serious reactions include seizures (especially in patients with kidney problems), allergic reactions, or changes in liver/kidney function.

Prescribed for moderate to severe infections like pneumonia, complicated urinary tract infections, intra-abdominal infections, gynecological infections, meningitis, and bloodstream infections. Also used when resistance to other antibiotics is suspected.

To be administered only under the supervision of a healthcare professional. Inform your doctor if you have a history of seizures, kidney issues, or allergies to beta-lactam antibiotics (penicillins, cephalosporins, carbapenems). Complete the full course as prescribed to avoid resistance.

Store in a cool, dry place below 25°C. Protect from light and moisture. Once reconstituted, the solution should be used immediately or as directed by a healthcare provider. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Meropenem 125 mg (10 ml / vial strength variant) in the PCD pharma franchise market?

Meropenem 125 mg formulation (as a lower-strength injectable presentation depending on packaging and dilution standards) is an antibiotic used for bacterial infections, including respiratory tract infections, urinary tract infections, skin infections, and complicated hospital-acquired infections. It belongs to the critical-care anti-infective segment, mainly used in hospital settings under medical supervision.

Why should medical distributors include this product in their range?

Medical distributors and wholesalers can benefit from steady hospital demand across general wards, ICUs, and emergency care units. Injectable antibiotics are essential hospital stock items, and different strength variants are used based on pediatric, adult, or dilution requirements, ensuring consistent institutional consumption.

Does Cafoli Lifecore offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in critical-care injectable and antibiotic segments with monopoly rights, quality manufacturing standards, and reliable hospital supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this antibiotic product?

Wholesalers and institutional suppliers benefit from continuous hospital procurement, ICU prescriptions, and surgical infection management demand, making injectable antibiotics a stable and high-volume pharmaceutical category when partnered with Cafoli Lifecare.

How can I become a distributor or franchise partner for this Meropenem formulation?

Medical distributors, stockists, and pharma professionals interested in hospital antibiotic injectables can contact Cafoli Lifecare to discuss product availability, dosing strengths, regulatory requirements, and PCD pharma franchise opportunities in the critical-care segment.